Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fucoidan-coated metal-organic framework nanoparticles for targeted delivery of nimodipine in subarachnoid hemorrhage-induced vasospasm.

Biomaterials science·2026
Same author

Resiquimod-loaded MOF525 enables synergistic photodynamic therapy and immunotherapy for colorectal cancer.

Nano convergence·2026
Same author

Metal-organic framework-integrated polyurethane foam dressing for active scavenging of pro-inflammatory chemokines in chronic wounds.

Biomaterials advances·2026
Same author

Functional hydrogels as submucosal injectable materials in therapeutic endoscopy.

Biomedical engineering letters·2026
Same author

Sulforaphane in Cancer Prevention and Therapy: A State-of-the-Art Review of Epidemiological Evidence, Molecular Mechanisms, and Translational Challenges.

International journal of molecular sciences·2026
Same author

Protein corona-guided delivery of dextran-PLGA NPs for enhanced dendritic cell uptake, maturation and improved cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Oct 9, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.3K

Immune cell targeting nanoparticles: a review.

Na Kyeong Lee1, Se-Na Kim2, Chun Gwon Park3,4,5,6

  • 1Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Gyeonggi, 16419, Republic of Korea.

Biomaterials Research
|December 21, 2021
PubMed
Summary
This summary is machine-generated.

Nanotechnology enables targeted delivery of therapeutics to specific immune cells, enhancing treatment efficacy and reducing side effects. Surface modification of nanoparticles allows precise targeting for various diseases, including cancer.

Keywords:
Active targetingEnzymatic responseImmune cellsNanoparticlesSurface modificationTarget drug deliveryTarget ligand

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.7K

Related Experiment Videos

Last Updated: Oct 9, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.3K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.7K

Area of Science:

  • Immunology
  • Nanotechnology
  • Drug Delivery

Background:

  • Immune cells play a crucial role in various diseases, making them attractive therapeutic targets.
  • Targeted delivery of therapeutic agents to specific immune cells can concentrate effects and minimize systemic side effects.

Purpose of the Study:

  • To explore the use of nanotechnology for targeted delivery of therapeutic agents to specific immune cells.
  • To highlight the advantages of nanoparticle-based delivery systems for enhanced therapeutic outcomes.

Main Methods:

  • Utilizing nanotechnology for distinguishing and targeting specific immune cells.
  • Employing surface modification of nanoparticles with active target ligands and enzyme-responsive coatings.
  • Delivering various substances, including drugs and genes, specifically to immune cells.

Main Results:

  • Nanoparticles offer in vivo stability and sustained drug release.
  • Surface-engineered nanoparticles successfully targeted specific immune cells.
  • Targeted delivery demonstrated significantly higher therapeutic effects compared to conventional treatments.

Conclusions:

  • Nanotechnology offers a breakthrough approach for targeted drug delivery to immune cells.
  • Surface modification of nanoparticles is key to achieving specific immune cell targeting.
  • This strategy holds promise for treating various diseases, including cancer.